All subjects (n=43) | | | | |
Breath number | 28.6±7.6 | 33.6±9.9 | 5.1 (1.4; 8.7)# | 17 |
VT mL | 276.5±58.3 | 263.3±53.8 | −13.2 (−1.1; −25.3)# | −4.8 |
CVVT % | 29.5±11.1 | 28.8±9.8 | −0.6 (2.2; −3.4) | −2.0 |
RR min−1 | 24.8±7.3 | 24.0±7.4 | −0.9 (−0.4; −2.1) | −3.6 |
V′E mL·min−1 | 6449.1±1370.6 | 5913.5±1020.1 | −535.6 (−234.7; −836.5)+ | −8.3 |
MTEF mL·s−1 | 196.5±47.8 | 179.9±33.9 | −16.6 (−7.7; −25.5)+ | −8.4 |
MTIF mL·s−1 | 245.8±45.9 | 230.2±37.3 | −15.6 (−7.0; −24.2)+ | −6.3 |
CO2 emitted mL | 9.2±2.4 | 8.7±2.3 | 0.5 (1.0; 0.1)# | 5.4 |
Healthy control subjects (n=15) | | | | |
Breath number | 27.5±7.5 | 31.3±7.1 | 3.7 (1.4; −1.6) | 13.5 |
VT mL | 284.8±65.2 | 263.5±46.2 | −21.2 (−1.0; −41.5)# | −7.4 |
CVVT % | 28.1±12.2 | 26.8±11.2 | −1.4 (4.1; −6.9) | −5.0 |
RR min−1 | 22.5±4.9 | 22.0±6.2 | −0.5 (1.6; −2.6) | −2.2 |
V′E mL·min−1 | 6073.4±1258.1 | 5563.6±962.1 | −509.8 (−14.6; −1005.0)# | −8.4 |
MTEF mL·s−1 | 191.7±45.2 | 168.5±29.0 | −23.2 (−9.5; −36.8)¶ | −12.1 |
MTIF mL·s−1 | 236.1±51.5 | 215.5±37.0 | −20.6 (−7.2; −34.1)¶ | −8.7 |
CO2 emitted mL | 9.3±2.6 | 8.6±2.0 | 0.4 (1.3; 0.2) | 7.5 |
Subjects with cystic fibrosis (n=28) | | | | |
Breath number | 29.1±7.7 | 34.9±11.1 | 5.8 (10.9; 0.7)# | 13.5 |
VT mL | 272.1±55.0 | 263.2±58.3 | −8.9 (6.9; −24.6) | −3.3 |
CVVT % | 30.2±10.5 | 29.9±9.0 | −0.2 (3.2; −3.6) | −0.7 |
RR min−1 | 26.1±8.1 | 25.0±7.8 | −1.0 (0.5; −2.6) | −3.8 |
V′E mL·min−1 | 6650.4±1407.4 | 6101.0±1017.1 | −549.4 (−147.9; −950.9)¶ | −8.3 |
MTEF mL·s−1 | 199.0±49.8 | 186.0±35.2 | −13.1 (−1.0; −25.1)# | −6.6 |
MTIF mL·s−1 | 251.0±42.8 | 238.1±35.6 | −12.9 (−1.4; −24.5)# | −5.1 |
CO2 emitted mL | 9.1±2.3 | 8.7±2.5 | 0.7 (1.3; 0.1)# | 7.7 |